Related Experiment Video
Updated: Jul 30, 2026
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.
M J McQueen1, E Lonn, H C Gerstein
1Hamilton Regional Laboratory Medicine Program, Department of Laboratory Medicine, St. Joseph's Hospital, Hamilton, Ontario. mcquemat@hhsc.ca
Summary
The HOPE study found that Ramipril, an ACE-inhibitor, significantly reduced cardiovascular events in high-risk individuals. Benefits were observed across diverse subgroups, including those with diabetes, highlighting Ramipril
Area of Science:
- Cardiovascular Medicine
- Clinical Trials
- Pharmacology
Background:
- The HOPE (Heart Outcomes Prevention Evaluation) study investigated interventions for cardiovascular disease prevention.
- High-risk populations, including those with diabetes, often face increased cardiovascular event risks.
Purpose of the Study:
- To evaluate the efficacy of Ramipril (an ACE-inhibitor) and Vitamin E in reducing cardiovascular events.
- To determine if Ramipril offers benefits across various patient subgroups and risk factors.
Main Methods:
- A prospective, randomized, multinational trial involving a high-risk population.
- Participants received either Ramipril, Vitamin E, or placebo.
Main Results:
- Ramipril significantly reduced the risk of future cardiovascular events, irrespective of diabetes status, hypertension, or existing cardiovascular disease.
- Vitamin E did not show a significant effect on cardiovascular event risk.
- Ramipril demonstrated benefits in patients with renal insufficiency and reduced new-onset diabetes.
Conclusions:
- Ramipril is a safe and cost-effective treatment for high-risk individuals to prevent cardiovascular events.
- The ACE-inhibitor Ramipril offers broad micro- and macrovascular benefits, including in patients with diabetes and renal insufficiency.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.